Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Neoadjuvant endocrine therapy|DRUG: Neoadjuvant chemotherapy
Sponsor: Ruijin Hospital